Mike Henos

No más puestos en curso

77 años

Health Technology

Finance

Distribution Services

Perfil

Mr. Mike A. Henos is General Partner & at Alliance Technology Ventures, and Co-Founder at ProMed Technologies, Inc. Prior to founding ATV in 1993, Mr. Henon was a General Partner with Aspen Venture Partners, where he was based in Menlo Park, CA. Prior to Aspen he was Vice President of 3i Ventures in Newport Beach, CA. From 1984 to 1986, he was a health care consultant with Ernst & Young, specializing in venture financing of start-up medical technology companies.
Prior to 1984, he served in a variety of management positions with Science Applications, the Revlon Healthcare Group and co-founded Pro Med Technologies, where he also served as its Chief Executive Officer.
He earned a BS in economics and an MBA from the University of California at Los Angeles (UCLA).

Antiguos cargos conocidos de Mike Henos.

Empresas	Cargo	Fin
Inhibitex LLC Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs	Presidente	13/02/2012
Sensys Medical Ltd. Sensys Medical Ltd. Medical DistributorsDistribution Services Develops and manufactures blood glucose monitoring devices	Director/Miembro de la Junta	03/03/2011
Genoptix, Inc. Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services	Director/Miembro de la Junta	01/02/2011
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Director/Miembro de la Junta	13/10/2009
AtheroGenics, Inc. AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases	Presidente	14/07/2009

Ver el detalle de la experiencia de Mike Henos.

Formación de Mike Henos.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mike Henos.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	11
AtheroGenics, Inc. AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases	Health Technology
Inhibitex LLC Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs	Health Technology
Sensys Medical Ltd. Sensys Medical Ltd. Medical DistributorsDistribution Services Develops and manufactures blood glucose monitoring devices	Distribution Services
Neuronyx, Inc. Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells	Health Technology
Genoptix, Inc. Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services	Health Services
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aspen Ventures Aspen Ventures Investment ManagersFinance Aspen Ventures looks for opportunities to invest in early-stage information technology companies located in the Western US, particularly those serving business markets. The firm does not invest in companies focused on consumer markets. Potential investments are evaluated against criteria that include compelling technology-based solutions that are differentiated and address large markets, entrepreneurial Management team and a well-formulated strategy.	Finance
GlycoMimetics, Inc. GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer	Health Technology
Alliance Technology Management Corp. Alliance Technology Management Corp. Investment ManagersFinance Alliance Technology Ventures focuses on investments in early-stage private companies located in the US. The firm targets companies operating in the field’s semiconductor, communication component and life science industries. They provide financing for seed, early, later stage capital requirements.	Finance
ProMed Technologies, Inc.
3i Ventures Corp.